4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-046369
EVP, Research & CSO sold 7,900 shares at $51.08 ($403,563)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-11 | Exercise or conversion : show line 1 in the form | +7,900 | $1.53 | $12,087 | 7,900 | D |
| 2020-08-11 | Sale : show line 2 in the form | −7,900 | $51.08 | $403,563 | 0 | D |
| Open-market sales · 7,900 sh · avg $51.08 · $403,563 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-11 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,900 | 500,255 | D |
Loading xslF345X03/doc4.xml…